Showing results (1-10 of 2,434) with videos related to
Sort By:
Pageof 244
Clinical Pharmacokinetics|December 1, 1996
Pharmacokinetics of opioids in renal dysfunctionG Davies, C Kingswood, M StreetJournal of Clinical Pharmacy and Therapeutics|January 6, 1999
Use of in vitro models of haemofiltration and haemodiafiltration to estimate dosage regimens for critically ill patients prescribed cefpiromeG J Phillips, J G Davies, C J Olliff, et al.British Journal of Hospital Medicine|November 12, 1995
Drug removal in continuous haemofiltration and haemodialysisJ G Davies, J C Kingswood, P Sharpstone, et al.The Annals of Pharmacotherapy|May 1, 1996
Quinine clearance in continuous venovenous hemofiltrationJ G Davies, E F Greenwood, J C Kingswood, et al.Therapeutic Advances in Urology|December 9, 2016
Optimal treatment of tuberous sclerosis complex associated renal angiomyolipomata: a systematic reviewJohn J Bissler, John C KingswoodOrphanet Journal of Rare Diseases|February 17, 2017
Management of everolimus-associated adverse events in patients with tuberous sclerosis complex: a practical guideMark Davies, Anurag Saxena, John C KingswoodBritish Journal of Hospital Medicine|May 1, 1990
Renal replacement therapy in the ICU: the role of continuous arteriovenous haemodialysisR Miller, C Kingswood, C Bullen, et al.Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1992
Comparison of the efficacy cost and complication rate of APD and CAPD as long-term outpatient treatments for renal failureL K King, J C Kingswood, P SharpstoneActa Endocrinologica|January 1, 1987
The effect of nadolol on heart rate in hyperthyroidism. A controlled trialJ H Lazarus, J C Kingswood, R JohnNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 18, 1999
End-stage renal failure in adults with the tuberous sclerosis complexA Clarke, E Hancock, C Kingswood, et al.Pageof 244